A new computational framework illuminates the hidden ecology of diseased tissues
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.
The findings provide new drug targets for stopping the infection’s spread.
Findings may help predict how rain and irrigation systems launch particles and pathogens from watery surfaces, with implications for industry, agriculture, and public health.
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Whitehead Institute and CSAIL researchers created a machine-learning model to predict and generate protein localization, with implications for understanding and remedying disease.
Xiao Wang’s studies of how and where RNA is translated could lead to the development of better RNA therapeutics and vaccines.
Studying the pathogen R. parkeri, researchers discovered the first evidence of extensive and stable interkingdom contacts between a pathogen and a eukaryotic organelle.
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
Using high-powered lasers, this new method could help biologists study the body’s immune responses and develop new medicines.
Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.
New research reveals what it takes for a protein that is best known for protecting cells against death to take on the opposite role.
Professors Matthew Vander Heiden and Fan Wang, along with five MIT alumni, are honored for their outstanding professional achievement and commitment to service.